Focus Stocks
Patience with IMAX
Published on Wednesday, 08 February 2012 09:04 Written by TradersHuddle Wire
New York, February 8th (TradersHuddle.com) - Shares of Imax Corporation (NASDAQ:IMAX) closed the trading session at $22.53 near its 200 day moving average currently set at $22.93. IMAX's price action is below this important level, which makes the stock difficult to buy, as there will certainly be resistance as it approaches its 200 day moving average.
Imax Corporation (NASDAQ:IMAX) specializes in motion picture technologies and large-format film presentations. The company designs and manufactures projection and sound systems for large-screen theaters and designs custom attractions, including motion simulation theaters, for both large-scale attractions and smaller venues.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $20.29 and calculated resistance at $22.52. These levels are being closely watched by traders, as they provide great reference points for the latest price dynamics in IMAX shares.
Traders should evaluate their trade if they want to establish a position on IMAX given the resistance could materialize as the stock approaches the 200 day moving average. A trade might materialize as the stock manages to break this important level, as it could be used as support going forward, however until the break materializes, traders need to exercise patience. Other levels that traders will be evaluating are the ones defined by the peak and troughs algorithm that provides great price action reference points.
Related Articles
- Bulls and Bears on the Trenches of IMAX
- Bears Appeared on IMAX
- Key Levels for IMAX
- Trading Idea: Entry Levels for IMAX
- IMAX, Reversal Soon?
- IMAX is Near a Key Support Area
- IMAX Is Close to its 50 Day Moving Average
- Is IMAX Close to Support?
- Trading Idea: What to Expect as IMAX Breaks Resistance
- Trading Idea: - Is IMAX close to Resistance?
Related Partner Headlines
- UPDATE: Imax Posts In-Line Q4 Profit - Benzinga
- Imax Rises On Unusually High Volume (IMAX) - TheStreet.com
- IMAX Expands Relationship With China's Broadway Theatre Company With Four Theatre Deal - Benzinga
- IMAX Partners With Barco to Co-Develop Next-Generation Laser Projection Technology - Benzinga
- Why You Shouldn't Believe the Netflix/Verizon Deal Rumors - TheStreet.com
- Imax Shares Jump on Upgrade, CEO Presentation - TheStreet.com
- Imax Stock Hits New 52-Week Low (IMAX) - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









